170 related articles for article (PubMed ID: 26343413)
1. A metabolomic perspective of griseofulvin-induced liver injury in mice.
Liu K; Yan J; Sachar M; Zhang X; Guan M; Xie W; Ma X
Biochem Pharmacol; 2015 Dec; 98(3):493-501. PubMed ID: 26343413
[TBL] [Abstract][Full Text] [Related]
2. Liver metabolomics in a mouse model of erythropoietic protoporphyria.
Wang P; Sachar M; Guo GL; Shehu AI; Lu J; Zhong XB; Ma X
Biochem Pharmacol; 2018 Aug; 154():474-481. PubMed ID: 29906468
[TBL] [Abstract][Full Text] [Related]
3. Hepatic damage and oxidative stress induced by Griseofulvin in mice.
Martinez Mdel C; Afonso SG; Meiss RP; Buzaleh AM; Batlle A
Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):127-39. PubMed ID: 19656461
[TBL] [Abstract][Full Text] [Related]
4. Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria.
Meerman L; Koopen NR; Bloks V; Van Goor H; Havinga R; Wolthers BG; Kramer W; Stengelin S; Müller M; Kuipers F; Jansen PL
Gastroenterology; 1999 Sep; 117(3):696-705. PubMed ID: 10464147
[TBL] [Abstract][Full Text] [Related]
5. Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
Duchartre Y; Petit N; Moya C; Lalanne M; Dubus P; Verneuil Hd; Moreau-Gaudry F; Richard E
J Hepatol; 2011 Jul; 55(1):162-70. PubMed ID: 21145811
[TBL] [Abstract][Full Text] [Related]
6. The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria.
Wang P; Sachar M; Lu J; Shehu AI; Zhu J; Chen J; Liu K; Anderson KE; Xie W; Gonzalez FJ; Klaassen CD; Ma X
Sci Adv; 2019 Sep; 5(9):eaaw6127. PubMed ID: 31555729
[TBL] [Abstract][Full Text] [Related]
7. Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool.
Davies R; Schuurman A; Barker CR; Clothier B; Chernova T; Higginson FM; Judah DJ; Dinsdale D; Edwards RE; Greaves P; Gant TW; Smith AG
Am J Pathol; 2005 Apr; 166(4):1041-53. PubMed ID: 15793285
[TBL] [Abstract][Full Text] [Related]
8. Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model.
Lyoumi S; Abitbol M; Rainteau D; Karim Z; Bernex F; Oustric V; Millot S; Lettéron P; Heming N; Guillmot L; Montagutelli X; Berdeaux G; Gouya L; Poupon R; Deybach JC; Beaumont C; Puy H
Gastroenterology; 2011 Oct; 141(4):1509-19, 1519.e1-3. PubMed ID: 21762662
[TBL] [Abstract][Full Text] [Related]
9. Experimental protoporphyria: effect of bile acids on liver damage induced by griseofulvin.
Martinez Mdel C; Ruspini SF; Afonso SG; Meiss R; Buzaleh AM; Batlle A
Biomed Res Int; 2015; 2015():436319. PubMed ID: 25945334
[TBL] [Abstract][Full Text] [Related]
10. Mdr P-glycoproteins are not essential for biliary excretion of the hydrophobic heme precursor protoporphyrin in a griseofulvin-induced mouse model of erythropoietic protoporphyria.
Plösch T; Bloks VW; Baller JF; Havinga R; Verkade HJ; Jansen PL; Kuipers F
Hepatology; 2002 Feb; 35(2):299-306. PubMed ID: 11826402
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: potential novel players in the progression of liver injury.
Berasain C; Sampedro A; Mauleón I; Goñi S; Latasa MU; Matscheko N; García-Bravo M; Unzu C; Corrales FJ; Enríquez de Salamanca R; Prieto J; Avila MA; Fontanellas A
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):29-37. PubMed ID: 19267999
[TBL] [Abstract][Full Text] [Related]
12. Mild iron deficiency does not ameliorate the phenotype of a murine erythropoietic protoporphyria model.
Schmidt PJ; Hollowell ML; Fitzgerald K; Butler JS; Fleming MD
Am J Hematol; 2020 May; 95(5):492-496. PubMed ID: 31990410
[TBL] [Abstract][Full Text] [Related]
13. Toxic effects of griseofulvin: disease models, mechanisms, and risk assessment.
Knasmüller S; Parzefall W; Helma C; Kassie F; Ecker S; Schulte-Hermann R
Crit Rev Toxicol; 1997 Sep; 27(5):495-537. PubMed ID: 9347226
[TBL] [Abstract][Full Text] [Related]
14. Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria.
Delaby C; Lyoumi S; Ducamp S; Martin-Schmitt C; Gouya L; Deybach JC; Beaumont C; Puy H
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):45-52. PubMed ID: 19268001
[TBL] [Abstract][Full Text] [Related]
15. Effect of decreased ferrochelatase activity on iron and porphyrin content in mitochondria of mice with porphyria induced by griseofulvin.
Tangerås A
Biochim Biophys Acta; 1986 Jun; 882(1):77-84. PubMed ID: 3707999
[TBL] [Abstract][Full Text] [Related]
16. Involvement of protoporphyrin IX accumulation in the pathogenesis of isoniazid/rifampicin-induced liver injury: the prevention of curcumin.
He L; Guo Y; Deng Y; Li C; Zuo C; Peng W
Xenobiotica; 2017 Feb; 47(2):154-163. PubMed ID: 28118809
[TBL] [Abstract][Full Text] [Related]
17. Protective action of antioxidants on hepatic damage induced by griseofulvin.
Martinez Mdel C; Afonso SG; Buzaleh AM; Batlle A
ScientificWorldJournal; 2014; 2014():982358. PubMed ID: 24523661
[TBL] [Abstract][Full Text] [Related]
18. Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.
Choi SW; Han JH; Lim KT; Cho HM; Chung KW; Sun HS; Park DH; Kim BS; Seo EJ
J Korean Med Sci; 1991 Jun; 6(2):146-56. PubMed ID: 1751019
[TBL] [Abstract][Full Text] [Related]
19. Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy.
Berenson MM; Welch V; Garcia-Marin JJ
J Lab Clin Med; 1991 Jul; 118(1):89-98. PubMed ID: 2066649
[TBL] [Abstract][Full Text] [Related]
20. Chronic Treatment with Isoniazid Causes Protoporphyrin IX Accumulation in Mouse Liver.
Sachar M; Li F; Liu K; Wang P; Lu J; Ma X
Chem Res Toxicol; 2016 Aug; 29(8):1293-7. PubMed ID: 27438535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
